Secondary sclerosing cholangitis and portal hypertension after O157 enterocolitis: Extremely rare complications of hemolytic uremic syndrome
Authors:
- 1 December 2001
- journal article
- case report
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 36 (12) , 1838-1840
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Clinical features and treatment of children with hemolytic uremic syndrome caused by enterohemorrhagic Escherichia coli O157:H7 infection: Experience of an outbreak in Sakai City, 1996Pediatrics International, 1999
- An Outbreak of Escherichia coli O157:H7 Infection from Unpasteurized Commercial Apple JuiceAnnals of Internal Medicine, 1999
- Inflammatory mediators in Escherichia coli O157:H7 hemorrhagic colitis and hemolytic-uremic syndromeThe Pediatric Infectious Disease Journal, 1998
- PROFILES OF CIRCULATING INFLAMMATORY AND ANTI-INFLAMMATORY CYTOKINES IN PATIENTS WITH HEMOLYTIC UREMIC SYNDROME DUE TOE. COLIO157 INFECTIONCytokine, 1998
- The Role of Lipopolysaccharide and Shiga-like Toxin in a Mouse Model of Escherichia coli O157:H7 InfectionThe Journal of Infectious Diseases, 1997
- Lessons learned in the management of hemolytic uremic syndrome in childrenJournal of Pediatric Surgery, 1995
- Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndromeThe Journal of Pediatrics, 1994
- Surgical complications of the hemolytic-uremic syndromeJournal of Pediatric Surgery, 1990
- Infection by verocytotoxin-producing Escherichia coliClinical Microbiology Reviews, 1989
- A Severe Outbreak ofEscherichia coliO157:H7–Associated Hemorrhagic Colitis in a Nursing HomeNew England Journal of Medicine, 1987